India's Pharmaceutical Exports

Country Profile

Guyana

Guyana is an emerging destination for Indian pharmaceutical exports — $20.0M in FY 2025–26, with 3.3× growth over the past decade. Medicines accounts for 87% of shipments, with vaccines contributing $440K. The compound annual growth rate since FY2015 stands at 11.5%.

🇬🇾 $20.0M · 3.3× growth since FY2015 · 11.5% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$20.0M
Exports FY2025–26 DGCIS
3.3×
Growth FY2015→2026
11.5%
CAGR FY2015→2026
87%
Medicines Share
5
Product Categories Supplied
Guyana is an emerging destination for Indian pharmaceutical exports — $20.0M in FY 2025–26, with 3.3× growth over the past decade. Medicines accounts for 87% of shipments, with vaccines contributing $440K. The compound annual growth rate since FY2015 stands at 11.5%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $17.3M (86.8%) Surgical & Hospital Supplies $1.79M (8.9%) Vaccines $440K (2.2%) Traditional & Herbal $326K (1.6%) Medicine Ingredients $79K (0.4%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Guyana in the RBI overseas direct investment dataset (2011–2026).